Skip to main content
TXG filings

Corporate insider profile

Shehnaaz Suliman Filing Activity

Latest reported as Director of 10x Genomics, Inc. (TXG).

Purchase filings
0
Reported companies
2
Net open-market value
-$330,945.17
Latest transaction
Jun 16, 2026

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jun 16, 202610x Genomics, Inc. (TXG)DirectorSale5,723$32.63$186,756
May 18, 2026Ultragenyx Pharmaceutical Inc. (RARE)DirectorSale5,740$25.12$144,189